desoxycorticosterone acetate has been researched along with Disease Models, Animal in 89 studies
Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our study demonstrated the protective effect of resveratrol and exercise on hypertension-induced cardiac dysfunction by modulating cellular stress responses including oxidative stress, ER stress, mitophagy, NLRP3 inflammasome-mediated inflammation, and mitogenic activation." | 8.12 | Resveratrol and regular exercise may attenuate hypertension-induced cardiac dysfunction through modulation of cellular stress responses. ( Bal, NB; Bostanci, A; Demirel-Yilmaz, E; Dönmez, MO; Sadi, G; Uludag, MO, 2022) |
| "Equol-treated DHRs showed a significant decrease in both the swimming distance and time required to reach the escape platform (78." | 5.43 | Effects of equol on deoxycorticosterone acetate salt-induced hypertension and associated vascular dementia in rats. ( Liu, TH; Tsai, TY, 2016) |
| "Our study demonstrated the protective effect of resveratrol and exercise on hypertension-induced cardiac dysfunction by modulating cellular stress responses including oxidative stress, ER stress, mitophagy, NLRP3 inflammasome-mediated inflammation, and mitogenic activation." | 4.12 | Resveratrol and regular exercise may attenuate hypertension-induced cardiac dysfunction through modulation of cellular stress responses. ( Bal, NB; Bostanci, A; Demirel-Yilmaz, E; Dönmez, MO; Sadi, G; Uludag, MO, 2022) |
| "Aspirin prevented aneurysm rupture in a mouse intracranial aneurysm model, while cilostazol did not." | 3.88 | Prevention Effect of Antiplatelets on Aneurysm Rupture in a Mouse Intracranial Aneurysm Model. ( Hiramatsu, H; Hokamura, K; Kamio, Y; Kimura, T; Makino, H; Namba, H; Suzuki, T; Umemura, K; Yamasaki, T, 2018) |
| "Chlorisondamine (CSD) has been used to assess the neurogenic contribution to blood pressure (BP) and vasomotor sympathetic tone in animal models." | 1.62 | Use of chlorisondamine to assess the neurogenic contribution to blood pressure in mice: An evaluation of method. ( Cooper, SG; Feng Earley, Y; Souza, LA; Thakore, P; Worker, CJ, 2021) |
| " In this study, we evaluated the efficacy of firibastat in combination with enalapril, an angiotensin I-converting enzyme inhibitor, and hydrochlorothiazide (HCTZ), in conscious hypertensive deoxycorticosterone acetate (DOCA)-salt rats, which display high plasma arginine-vasopressin levels, low circulating renin levels and resistance to treatment by systemic RAS blockers." | 1.62 | Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats. ( Balavoine, F; De Mota, N; Hmazzou, R; Llorens-Cortes, C; Marc, Y, 2021) |
| "Hypertension was induced in swine by subcutaneous implantation of deoxycorticosterone acetate pellets in combination with a high-salt diet." | 1.62 | Renal Denervation by Noninvasive Stereotactic Radiotherapy Induces Persistent Reduction of Sympathetic Activity in a Hypertensive Swine Model. ( Cai, J; Cai, X; Chen, T; Chen, X; Chi, R; Fei, Y; Han, Y; Jiang, M; Li, K; Li, YG; Liu, M; Liu, Y; Qian, L; Shen, Y; Wang, D; Wang, W; Wei, Z; Yang, Y; Yu, S, 2021) |
| "Hypertension is an important risk factor for cardiovascular diseases." | 1.56 | Reversal of deleterious effect of hypertension on the liver by inhibition of endoplasmic reticulum stress. ( Bal, NB; Demirel-Yilmaz, E; Han, S; Kiremitci, S; Uludag, MO, 2020) |
| "Hypertension was induced by deoxycorticosterone acetate (DOCA)-salt administration in uninephrectomized rats for 6 weeks." | 1.51 | Activation of Liver X Receptors by GW3965 Attenuated Deoxycorticosterone Acetate-Salt Hypertension-Induced Cardiac Functional and Structural Changes. ( Bal, NB; Demirel-Yilmaz, E; Han, S; Kiremitci, S; Sadi, G; Uludag, O; Usanmaz, SE, 2019) |
| "Hypertension was induced by deoxycorticosterone-acetate (DOCA) and salt administration in uni-nephrectomized rats for 12 weeks." | 1.51 | Hypertension-induced cardiac impairment is reversed by the inhibition of endoplasmic reticulum stress. ( Bal, NB; Demirel-Yilmaz, E; Han, S; Kiremitci, S; Sadi, G; Uludag, O, 2019) |
| "Aldosterone is a key factor in adverse cardiovascular remodeling by acting on the mineralocorticoid receptor (MR) in different cell types." | 1.51 | Endothelial cell mineralocorticoid receptors oppose VEGF-induced gene expression and angiogenesis. ( Bode, C; Deng, L; Esser, JS; Fürst, D; Hein, L; Huck, M; Kowalski, J; Lother, A; Moser, M, 2019) |
| "Hypertension has complex vascular pathogenesis and therefore the molecular etiology remains poorly elucidated." | 1.51 | Inhibition of endoplasmic reticulum stress protected DOCA-salt hypertension-induced vascular dysfunction. ( Bal, NB; Demirel-Yilmaz, E; Han, S; Sadi, G; Tuglu, MM; Uludag, MO; Usanmaz, SE, 2019) |
| " The aim of this study was to compare the effect of chronic administration of URB597, the FAAH (fatty acid amide hydrolase) inhibitor, to rats with primary (SHRs) and secondary (DOCA-salt hypertensive rats) hypertension on electrical and physicochemical properties of kidney cells membranes." | 1.51 | Changes in physicochemical properties of kidney cells membrane as a consequence of hypertension and treatment of hypertensive rats with FAAH inhibitor. ( Dobrzyńska, I; Figaszewski, ZA; Skrzydlewska, E; Szachowicz-Petelska, B; Weresa, J, 2019) |
| "Metformin-treated mice have unaltered PEVK phosphorylation but increased phosphorylation of PKA sites in the N2B element, a change which has previously been shown to lower titin's stiffness." | 1.51 | Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance. ( Gotthardt, M; Granzier, HL; Liss, M; Methawasin, M; Slater, RE; Strom, JG; Sweitzer, N, 2019) |
| "Protocatechuic acid (PCA) is a natural antioxidant with beneficial cardiovascular properties." | 1.48 | Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats. ( Emami, R; Haghighatian, Z; Hajhashemi, V; Safaeian, L, 2018) |
| "Hypertension was induced through unilateral nephrectomy and deoxycorticosterone-acetate (DOCA) injection (20 mg/kg, twice a week) for 6 weeks in male Wistar albino rats (8 weeks old)." | 1.48 | The effects of LXR agonist GW3965 on vascular reactivity and inflammation in hypertensive rat aorta. ( Bal, NB; Demirel-Yilmaz, E; Han, S; Sadi, G; Uludag, MO; Usanmaz, SE, 2018) |
| "Hypertension was promoted by subcutaneous injection of deoxycorticosterone acetate (DOCA, 25 mg/kg body weight/day, twice a week) and substitution of drinking water with 1." | 1.46 | Prevention of hypertension-induced vascular dementia by Lactobacillus paracasei subsp. paracasei NTU 101-fermented products. ( Cheng, MC; Pan, TM, 2017) |
| "Equol-treated DHRs showed a significant decrease in both the swimming distance and time required to reach the escape platform (78." | 1.43 | Effects of equol on deoxycorticosterone acetate salt-induced hypertension and associated vascular dementia in rats. ( Liu, TH; Tsai, TY, 2016) |
| "Because hypertension is characterized by arterial remodeling, we hypothesized that TG activity, expression, and functionality would be increased in the aorta, but not in the vena cava (which does not undergo remodeling), from hypertensive rats relative to normotensive rats." | 1.42 | Transglutaminase activity is decreased in large arteries from hypertensive rats compared with normotensive controls. ( Hitomi, K; Johnson, KB; Petersen-Jones, HG; Thompson, JM; Tykocki, NR; Watts, SW, 2015) |
| "Hypertension was induced by injection of DOCA-salt (25 mg/kg, s." | 1.42 | Supplementation of apelin increase plasma levels of nesfatin-1 in normal and DOCA-salt hypertensive rats. ( Akcilar, R; Ayada, C; Turgut, G; Turgut, S, 2015) |
| "This agent could be useful for the treatment of hypertension, cardiovascular and renal disorders." | 1.42 | Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist. ( Aoki, K; Arai, K; Homma, T; Ishikawa, H; Mizuno, M; Morikawa, Y; Sada, T; Tsuruoka, H; Ubukata, N, 2015) |
| "We induced hypertension and hyperlipidemia in landrace pigs (n = 8) by deoxycorticosteroneacetate (DOCA, 100 mg/kg, 90-day-release subcutaneous depot) and a Western diet (WD) containing high amounts of salt, fat, cholesterol, and sugar for 12 wk." | 1.42 | A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction. ( Alogna, A; Casadei, B; Eller, K; Eller, P; Hamdani, N; Höfler, G; Kirsch, A; Linke, WA; Maechler, H; Manninger, M; Pieske, BM; Post, H; Reilly, S; Schauer, S; Schwarzl, M; Seiler, S; Steendijk, P; Verderber, J; Zirngast, B; Zweiker, D, 2015) |
| " In order to identify pharmacokinetic changes (mainly non-renal clearance, CLNR) in 16-week-old SHRs due to hereditary characteristics and/or neither the hypertensive state itself, we reviewed the pharmacokinetics of drugs in 6- (blood pressure within a normotensive range) and 16-week-old SHRs and 16-week-old DOCA-salt rats compared with respective control rats." | 1.40 | Pharmacokinetics of drugs in spontaneously or secondary hypertensive rats. ( Lee, YS; Oh, E; Yang, S, 2014) |
| "Spironolactone treatment prevented Th17 cell activation and increased numbers of forkhead box P3-positive cells relative to DOCA-salt rats." | 1.40 | Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes. ( Alzamora, R; Amador, CA; Barrientos, V; Carrasco, L; Figueroa, F; González, M; Herrada, AA; Kalergis, AM; Michea, L; Peña, J; Valdés, S, 2014) |
| "Lacidipine-treated group (5) showed a significant reduction in elevated systolic blood pressure together with a great protection of ALT and SOD enzymes from the destructive effects of irradiation and hypertension." | 1.39 | Possible hepatoprotective effects of lacidipine in irradiated DOCA-salt hypertensive albino rats. ( Kamal, SM, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 67 (75.28) | 24.3611 |
| 2020's | 22 (24.72) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 2 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Robles-Vera, I | 1 |
| de la Visitación, N | 1 |
| Toral, M | 1 |
| Sánchez, M | 1 |
| Romero, M | 1 |
| Gómez-Guzmán, M | 1 |
| Vargas, F | 1 |
| Duarte, J | 1 |
| Jiménez, R | 1 |
| Bal, NB | 6 |
| Bostanci, A | 1 |
| Sadi, G | 5 |
| Dönmez, MO | 1 |
| Uludag, MO | 4 |
| Demirel-Yilmaz, E | 6 |
| Benson, LN | 1 |
| Liu, Y | 3 |
| Wang, X | 1 |
| Xiong, Y | 1 |
| Rhee, SW | 1 |
| Guo, Y | 1 |
| Deck, KS | 1 |
| Mora, CJ | 1 |
| Li, LX | 1 |
| Huang, L | 1 |
| Andrews, JT | 1 |
| Qin, Z | 1 |
| Hoover, RS | 1 |
| Ko, B | 1 |
| Williams, RM | 1 |
| Heller, DA | 1 |
| Jaimes, EA | 1 |
| Mu, S | 1 |
| Thowsen, IM | 1 |
| Reikvam, T | 1 |
| Skogstrand, T | 1 |
| Samuelsson, AM | 1 |
| Müller, DN | 1 |
| Tenstad, O | 1 |
| Alitalo, K | 1 |
| Karlsen, T | 1 |
| Wiig, H | 1 |
| Guy, R | 1 |
| Herman, S | 1 |
| Benyamini, H | 1 |
| Ben-Zur, T | 1 |
| Kobo, H | 1 |
| Pasmanik-Chor, M | 1 |
| Yaacobi, D | 1 |
| Barel, E | 1 |
| Yagil, C | 1 |
| Yagil, Y | 1 |
| Offen, D | 1 |
| Han, S | 5 |
| Usanmaz, SE | 3 |
| Kiremitci, S | 3 |
| Uludag, O | 2 |
| Yao, NA | 1 |
| Niazi, ZR | 1 |
| Najmanová, I | 1 |
| Kamagaté, M | 1 |
| Said, A | 1 |
| Chabert, P | 1 |
| Auger, C | 1 |
| Die-Kakou, H | 1 |
| Schini-Kerth, V | 1 |
| Atchison, DK | 1 |
| O'Connor, CL | 1 |
| Menon, R | 1 |
| Otto, EA | 1 |
| Ganesh, SK | 1 |
| Wiggins, RC | 1 |
| Smrcka, AV | 1 |
| Bitzer, M | 1 |
| Lyu, B | 1 |
| Wang, W | 2 |
| Ji, XY | 1 |
| Ritter, JK | 1 |
| Li, N | 1 |
| Chen, Y | 1 |
| Dale, BL | 1 |
| Alexander, MR | 1 |
| Xiao, L | 1 |
| Ao, M | 1 |
| Pandey, AK | 1 |
| Smart, CD | 1 |
| Davis, GK | 1 |
| Madhur, MS | 1 |
| Wang, F | 1 |
| Sun, Y | 1 |
| Luo, R | 1 |
| Lu, X | 1 |
| Yang, B | 1 |
| Yang, T | 1 |
| Fan, L | 1 |
| Gao, W | 1 |
| Nguyen, BV | 1 |
| Jefferson, JR | 1 |
| Fan, F | 1 |
| Roman, RJ | 1 |
| Jin, X | 1 |
| Kim, WB | 1 |
| Kim, MN | 1 |
| Jung, WW | 1 |
| Kang, HK | 1 |
| Hong, EH | 1 |
| Kim, YS | 1 |
| Shim, WJ | 1 |
| Han, HC | 1 |
| Colwell, CS | 1 |
| Kim, YB | 1 |
| Kim, YI | 1 |
| Souza-Paula, E | 1 |
| Polonio, LCC | 1 |
| Zochio, GP | 1 |
| da Silva, KP | 1 |
| Kushima, H | 1 |
| Dias-Junior, CA | 1 |
| Zhang, J | 2 |
| Zhu, M | 1 |
| Zhang, S | 1 |
| Xie, S | 1 |
| Gao, Y | 1 |
| Wang, Y | 1 |
| Nwokocha, CR | 1 |
| Gordon, A | 1 |
| Palacios, J | 1 |
| Paredes, A | 1 |
| Cifuentes, F | 1 |
| Francis, S | 1 |
| Watson, J | 1 |
| Delgoda, R | 1 |
| Nwokocha, M | 1 |
| Alexander-Lindo, R | 1 |
| Thompson, R | 1 |
| Minott-Kates, D | 1 |
| Yakubu, MA | 1 |
| Wu, X | 1 |
| Liu, X | 2 |
| Yang, H | 1 |
| Chen, Q | 1 |
| Zhang, N | 1 |
| Li, Y | 2 |
| Du, X | 1 |
| Jiang, X | 1 |
| Jiang, Y | 1 |
| Zhou, Z | 1 |
| Yang, Z | 1 |
| Souza, LA | 1 |
| Cooper, SG | 1 |
| Worker, CJ | 2 |
| Thakore, P | 1 |
| Feng Earley, Y | 1 |
| Hmazzou, R | 2 |
| Marc, Y | 2 |
| Flahault, A | 1 |
| Gerbier, R | 1 |
| De Mota, N | 2 |
| Llorens-Cortes, C | 2 |
| Balavoine, F | 1 |
| Cai, X | 1 |
| Shen, Y | 2 |
| Yang, Y | 1 |
| Qian, L | 1 |
| Cai, J | 1 |
| Chi, R | 1 |
| Yu, S | 1 |
| Li, K | 1 |
| Wei, Z | 1 |
| Chen, T | 1 |
| Fei, Y | 1 |
| Han, Y | 1 |
| Chen, X | 1 |
| Liu, M | 1 |
| Wang, D | 1 |
| Jiang, M | 1 |
| Li, YG | 1 |
| van Thiel, BS | 1 |
| Góes Martini, A | 1 |
| Te Riet, L | 1 |
| Severs, D | 1 |
| Uijl, E | 1 |
| Garrelds, IM | 1 |
| Leijten, FPJ | 1 |
| van der Pluijm, I | 1 |
| Essers, J | 1 |
| Qadri, F | 1 |
| Alenina, N | 1 |
| Bader, M | 1 |
| Paulis, L | 1 |
| Rajkovicova, R | 1 |
| Domenig, O | 1 |
| Poglitsch, M | 1 |
| Danser, AHJ | 1 |
| Liu, S | 2 |
| Gong, MC | 2 |
| Guo, Z | 2 |
| Polak, A | 1 |
| Harasim-Symbor, E | 1 |
| Malinowska, B | 1 |
| Kasacka, I | 1 |
| Pędzińska-Betiuk, A | 1 |
| Weresa, J | 2 |
| Chabowski, A | 1 |
| Perrotta, M | 1 |
| Lori, A | 1 |
| Carnevale, L | 1 |
| Fardella, S | 1 |
| Cifelli, G | 1 |
| Iacobucci, R | 1 |
| Mastroiacovo, F | 1 |
| Iodice, D | 1 |
| Pallante, F | 1 |
| Storto, M | 1 |
| Lembo, G | 1 |
| Carnevale, D | 1 |
| Mui, RK | 1 |
| Fernandes, RN | 1 |
| Garver, HG | 1 |
| Van Rooijen, N | 1 |
| Galligan, JJ | 1 |
| Douma, LG | 1 |
| Holzworth, MR | 1 |
| Solocinski, K | 1 |
| Masten, SH | 1 |
| Miller, AH | 1 |
| Cheng, KY | 1 |
| Lynch, IJ | 1 |
| Cain, BD | 1 |
| Wingo, CS | 1 |
| Gumz, ML | 1 |
| Safaeian, L | 1 |
| Emami, R | 1 |
| Hajhashemi, V | 1 |
| Haghighatian, Z | 1 |
| Lutshumba, J | 1 |
| Zhong, Y | 1 |
| Hou, T | 1 |
| Daugherty, A | 1 |
| Lu, H | 1 |
| Cassinotti, LR | 1 |
| Guil, MJ | 2 |
| Schöller, MI | 1 |
| Navarro, MP | 1 |
| Bianciotti, LG | 2 |
| Vatta, MS | 2 |
| Suzuki, T | 1 |
| Kamio, Y | 1 |
| Makino, H | 1 |
| Hokamura, K | 1 |
| Kimura, T | 1 |
| Yamasaki, T | 1 |
| Hiramatsu, H | 1 |
| Umemura, K | 1 |
| Namba, H | 1 |
| Tian, M | 1 |
| Tang, L | 1 |
| Wu, Y | 1 |
| Beddhu, S | 1 |
| Huang, Y | 1 |
| Collister, JP | 1 |
| Nahey, DB | 1 |
| Hartson, R | 1 |
| Wiedmeyer, CE | 1 |
| Banek, CT | 3 |
| Osborn, JW | 3 |
| Biernacki, M | 1 |
| Łuczaj, W | 1 |
| Jarocka-Karpowicz, I | 1 |
| Ambrożewicz, E | 1 |
| Toczek, M | 1 |
| Skrzydlewska, E | 2 |
| Dash, JR | 1 |
| Mishra, SK | 1 |
| Parida, S | 1 |
| Singh, TU | 1 |
| Choudhury, S | 1 |
| Muniyappa, K | 1 |
| Krishnan, SM | 1 |
| Ling, YH | 1 |
| Huuskes, BM | 1 |
| Ferens, DM | 1 |
| Saini, N | 1 |
| Chan, CT | 1 |
| Diep, H | 1 |
| Kett, MM | 1 |
| Samuel, CS | 1 |
| Kemp-Harper, BK | 1 |
| Robertson, AAB | 1 |
| Cooper, MA | 1 |
| Peter, K | 1 |
| Latz, E | 1 |
| Mansell, AS | 1 |
| Sobey, CG | 1 |
| Drummond, GR | 1 |
| Vinh, A | 1 |
| Lother, A | 2 |
| Deng, L | 1 |
| Huck, M | 1 |
| Fürst, D | 2 |
| Kowalski, J | 1 |
| Esser, JS | 1 |
| Moser, M | 2 |
| Bode, C | 2 |
| Hein, L | 2 |
| Tuglu, MM | 1 |
| Dobrzyńska, I | 1 |
| Szachowicz-Petelska, B | 1 |
| Figaszewski, ZA | 1 |
| Slater, RE | 1 |
| Strom, JG | 1 |
| Methawasin, M | 1 |
| Liss, M | 1 |
| Gotthardt, M | 1 |
| Sweitzer, N | 1 |
| Granzier, HL | 1 |
| Bae, EH | 2 |
| Kim, IJ | 1 |
| Song, JH | 1 |
| Choi, HS | 1 |
| Kim, CS | 1 |
| Eom, GH | 1 |
| Kim, I | 1 |
| Cha, H | 1 |
| Cho, JM | 1 |
| Ma, SK | 1 |
| Kim, SW | 2 |
| Gauthier, MM | 1 |
| Van Helden, DA | 1 |
| Fink, GD | 1 |
| Koizumi, T | 1 |
| Taguchi, K | 1 |
| Mizuta, I | 1 |
| Toba, H | 1 |
| Ohigashi, M | 1 |
| Onishi, O | 1 |
| Ikoma, K | 1 |
| Miyata, S | 1 |
| Nakata, T | 1 |
| Tanaka, M | 1 |
| Foulquier, S | 1 |
| Steinbusch, HWM | 1 |
| Mizuno, T | 1 |
| Pitra, S | 1 |
| Feng, Y | 3 |
| Stern, JE | 1 |
| Chugh, PK | 1 |
| Gupta, M | 1 |
| Agarwal, M | 1 |
| Tekur, U | 1 |
| Blattner, SM | 1 |
| Hodgin, JB | 1 |
| Nishio, M | 1 |
| Wylie, SA | 1 |
| Saha, J | 1 |
| Soofi, AA | 1 |
| Vining, C | 1 |
| Randolph, A | 1 |
| Herbach, N | 1 |
| Wanke, R | 1 |
| Atkins, KB | 1 |
| Gyung Kang, H | 1 |
| Henger, A | 1 |
| Brakebusch, C | 1 |
| Holzman, LB | 1 |
| Kretzler, M | 1 |
| Yang, S | 1 |
| Lee, YS | 1 |
| Oh, E | 1 |
| Kee, HJ | 1 |
| Park, S | 1 |
| Lee, KE | 1 |
| Suh, SH | 1 |
| Jeong, MH | 1 |
| Xia, H | 3 |
| Sriramula, S | 3 |
| Chhabra, KH | 1 |
| Lazartigues, E | 3 |
| Wehrwein, EA | 1 |
| Novotny, M | 1 |
| Swain, GM | 1 |
| Parker, LM | 1 |
| Esfahanian, M | 1 |
| Spitsbergen, JM | 1 |
| Habecker, BA | 1 |
| Kreulen, DL | 1 |
| Rodrigues, SF | 1 |
| Almeida-Paula, LD | 1 |
| Granger, DN | 1 |
| Amador, CA | 1 |
| Barrientos, V | 1 |
| Peña, J | 1 |
| Herrada, AA | 1 |
| González, M | 1 |
| Valdés, S | 1 |
| Carrasco, L | 1 |
| Alzamora, R | 1 |
| Figueroa, F | 1 |
| Kalergis, AM | 1 |
| Michea, L | 1 |
| Kamal, SM | 1 |
| Lin, JW | 1 |
| Tsai, CC | 1 |
| Chen, LJ | 1 |
| Niu, HS | 1 |
| Chang, CK | 1 |
| Niu, CS | 1 |
| Ighodaro, I | 1 |
| Eric, OK | 1 |
| Adebayo, O | 1 |
| Hernandez, ME | 1 |
| Hayward, LF | 1 |
| Zhang, Q | 1 |
| Tan, Y | 1 |
| Xu, P | 1 |
| de Queiroz, TM | 1 |
| Johnson, T | 1 |
| Mungrue, IN | 1 |
| Grigson, PS | 1 |
| Colechio, EM | 1 |
| Power, ML | 1 |
| Schulkin, J | 1 |
| Norgren, R | 1 |
| Ruan, CC | 1 |
| Ge, Q | 1 |
| Li, XD | 1 |
| Chen, DR | 1 |
| Ji, KD | 1 |
| Wu, YJ | 1 |
| Sheng, LJ | 1 |
| Yan, C | 1 |
| Zhu, DL | 1 |
| Gao, PJ | 1 |
| Petersen-Jones, HG | 1 |
| Johnson, KB | 1 |
| Hitomi, K | 1 |
| Tykocki, NR | 1 |
| Thompson, JM | 1 |
| Watts, SW | 1 |
| Akcilar, R | 1 |
| Ayada, C | 1 |
| Turgut, G | 1 |
| Turgut, S | 2 |
| Abramoff, T | 1 |
| Morales, VP | 1 |
| Hope, SI | 1 |
| Höcht, C | 1 |
| Dai, SY | 1 |
| Peng, W | 1 |
| Zhang, YP | 1 |
| Li, JD | 1 |
| Sun, XF | 1 |
| Jo, F | 1 |
| Jo, H | 1 |
| Hilzendeger, AM | 2 |
| Thompson, AP | 1 |
| Cassell, MD | 1 |
| Rutkowski, DT | 1 |
| Davisson, RL | 1 |
| Grobe, JL | 2 |
| Sigmund, CD | 2 |
| Liu, J | 1 |
| Hammond, SL | 1 |
| Tjalkens, RB | 1 |
| Saifudeen, Z | 1 |
| Liu, CT | 1 |
| Chien, SP | 1 |
| Hsu, DZ | 1 |
| Periasamy, S | 1 |
| Liu, MY | 1 |
| Mohammed-Ali, Z | 1 |
| Cruz, GL | 1 |
| Lu, C | 1 |
| Carlisle, RE | 1 |
| Werner, KE | 1 |
| Ask, K | 1 |
| Dickhout, JG | 1 |
| Arai, K | 1 |
| Homma, T | 1 |
| Morikawa, Y | 1 |
| Ubukata, N | 1 |
| Tsuruoka, H | 1 |
| Aoki, K | 1 |
| Ishikawa, H | 1 |
| Mizuno, M | 1 |
| Sada, T | 1 |
| de Almeida, PW | 1 |
| Melo, MB | 1 |
| Lima, Rde F | 1 |
| Gavioli, M | 1 |
| Santiago, NM | 1 |
| Greco, L | 1 |
| Jesus, IC | 1 |
| Nocchi, E | 1 |
| Parreira, A | 1 |
| Alves, MN | 1 |
| Mitraud, L | 1 |
| Resende, RR | 1 |
| Campagnole-Santos, MJ | 1 |
| Dos Santos, RA | 1 |
| Guatimosim, S | 1 |
| Sun, GQ | 1 |
| Li, YB | 1 |
| Du, B | 1 |
| Meng, Y | 1 |
| Jabaris, SS | 1 |
| Sumathy, H | 1 |
| Girish, R | 1 |
| Narayanan, S | 1 |
| Sugumar, M | 1 |
| Saravana Babu, C | 1 |
| Thanikachalam, S | 1 |
| Thanikachalam, M | 1 |
| Zhao, Q | 1 |
| Wang, H | 1 |
| Schwarzl, M | 1 |
| Hamdani, N | 1 |
| Seiler, S | 1 |
| Alogna, A | 1 |
| Manninger, M | 1 |
| Reilly, S | 1 |
| Zirngast, B | 1 |
| Kirsch, A | 1 |
| Steendijk, P | 1 |
| Verderber, J | 1 |
| Zweiker, D | 1 |
| Eller, P | 1 |
| Höfler, G | 1 |
| Schauer, S | 1 |
| Eller, K | 1 |
| Maechler, H | 1 |
| Pieske, BM | 1 |
| Linke, WA | 1 |
| Casadei, B | 1 |
| Post, H | 1 |
| Rathee, JS | 1 |
| Patro, BS | 1 |
| Brown, L | 1 |
| Chattopadhyay, S | 1 |
| Bergemann, S | 1 |
| Gilsbach, R | 1 |
| Grahammer, F | 1 |
| Huber, TB | 1 |
| Hilgendorf, I | 1 |
| Ketsawatsomkron, P | 1 |
| Keen, HL | 1 |
| Davis, DR | 1 |
| Lu, KT | 1 |
| Stump, M | 1 |
| De Silva, TM | 1 |
| Faraci, FM | 1 |
| Silva, GC | 1 |
| Silva, JF | 1 |
| Diniz, TF | 1 |
| Lemos, VS | 1 |
| Cortes, SF | 1 |
| Batchu, N | 1 |
| Hughson, A | 1 |
| Wadosky, KM | 1 |
| Morrell, CN | 1 |
| Fowell, DJ | 1 |
| Korshunov, VA | 1 |
| Liu, TH | 1 |
| Tsai, TY | 1 |
| Knuepfer, MM | 1 |
| Foss, JD | 1 |
| Fiege, JK | 1 |
| Asirvatham-Jeyaraj, N | 1 |
| Van Helden, D | 1 |
| Shimizu, Y | 1 |
| Marques, FZ | 1 |
| Nelson, E | 1 |
| Chu, PY | 1 |
| Horlock, D | 1 |
| Fiedler, A | 1 |
| Ziemann, M | 1 |
| Tan, JK | 1 |
| Kuruppu, S | 1 |
| Rajapakse, NW | 1 |
| El-Osta, A | 1 |
| Mackay, CR | 1 |
| Kaye, DM | 1 |
| Cheng, MC | 1 |
| Pan, TM | 1 |
| Kursunluoglu-Akcilar, R | 1 |
| Kilic-Toprak, E | 1 |
| Kilic-Erkek, O | 1 |
| Bor-Kucukatay, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Innovative Natural Dietary Formulation on Primary Hypertension and the Underlying Mechanism of Gut Microbiome Restoration: Pilot Study[NCT04403347] | Early Phase 1 | 90 participants (Anticipated) | Interventional | 2021-07-08 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
89 other studies available for desoxycorticosterone acetate and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Changes in Gut Microbiota Induced by Doxycycline Influence in Vascular Function and Development of Hypertension in DOCA-Salt Rats.
Topics: Animals; Anti-Bacterial Agents; Desoxycorticosterone Acetate; Disease Models, Animal; Doxycycline; E | 2021 |
Resveratrol and regular exercise may attenuate hypertension-induced cardiac dysfunction through modulation of cellular stress responses.
Topics: Animals; Desoxycorticosterone Acetate; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene Ex | 2022 |
The IFNγ-PDL1 Pathway Enhances CD8T-DCT Interaction to Promote Hypertension.
Topics: Animals; CD8-Positive T-Lymphocytes; Desoxycorticosterone Acetate; Disease Models, Animal; Hypertens | 2022 |
Genetic Engineering of Lymphangiogenesis in Skin Does Not Affect Blood Pressure in Mouse Models of Salt-Sensitive Hypertension.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Desoxycorticosterone Acetate; Disease Models, Animal; | 2022 |
Mesenchymal Stem Cell-Derived Extracellular Vesicles as Proposed Therapy in a Rat Model of Cerebral Small Vessel Disease.
Topics: Animals; Anti-Inflammatory Agents; Cerebral Small Vessel Diseases; Desoxycorticosterone Acetate; Dis | 2022 |
Activation of Liver X Receptors by GW3965 Attenuated Deoxycorticosterone Acetate-Salt Hypertension-Induced Cardiac Functional and Structural Changes.
Topics: Animals; Apoptosis; Benzoates; Benzylamines; Blood Pressure; Desoxycorticosterone Acetate; Disease M | 2019 |
Hypertension-induced cardiac impairment is reversed by the inhibition of endoplasmic reticulum stress.
Topics: Animals; Apoptosis; Blood Pressure; Calcium; Desoxycorticosterone Acetate; Disease Models, Animal; E | 2019 |
Reversal of deleterious effect of hypertension on the liver by inhibition of endoplasmic reticulum stress.
Topics: Animals; Blood Pressure; Desoxycorticosterone Acetate; Disease Models, Animal; Endoplasmic Reticulum | 2020 |
Preventive Beneficial Effect of an Aqueous Extract of Phyllanthus amarus Schum. and Thonn. (Euphorbiaceae) on DOCA-Salt-Induced Hypertension, Cardiac Hypertrophy and Dysfunction, and Endothelial Dysfunction in Rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cyclooxygenase 2; Desoxycorticosterone Acetate; Di | 2020 |
Hypertension induces glomerulosclerosis in phospholipase C-ε1 deficiency.
Topics: Albuminuria; Animals; Blood Pressure; Desoxycorticosterone Acetate; Disease Models, Animal; Female; | 2020 |
Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
Topics: Actins; Albuminuria; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blotting, Wes | 2020 |
Class switching and high-affinity immunoglobulin G production by B cells is dispensable for the development of hypertension in mice.
Topics: Angiotensin II; Animals; Antibody Affinity; Aorta; Blood Pressure; Cells, Cultured; Cytidine Deamina | 2021 |
COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats.
Topics: Animals; Blood Pressure; Cardiomegaly; Cyclooxygenase 2; Desoxycorticosterone Acetate; Disease Model | 2020 |
Impaired renal hemodynamics and glomerular hyperfiltration contribute to hypertension-induced renal injury.
Topics: Animals; Arterioles; Blood Pressure; Calmodulin-Binding Proteins; Desoxycorticosterone Acetate; Dise | 2020 |
Oestrogen inhibits salt-dependent hypertension by suppressing GABAergic excitation in magnocellular AVP neurons.
Topics: Animals; Antihypertensive Agents; Arginine Vasopressin; Basal Nucleus of Meynert; Blood Pressure; De | 2021 |
Anticontractile Effect of Perivascular Adipose Tissue But Not of Endothelium Is Enhanced by Hydrogen Sulfide Stimulation in Hypertensive Pregnant Rat Aortae.
Topics: Adaptation, Physiological; Adipose Tissue; Animals; Aorta, Thoracic; Desoxycorticosterone Acetate; D | 2020 |
Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
Topics: Animals; Anti-Inflammatory Agents; Cell Adhesion Molecules; Cytokines; Desoxycorticosterone Acetate; | 2020 |
Hypotensive and antihypertensive effects of an aqueous extract from Guinep fruit (Melicoccus bijugatus Jacq) in rats.
Topics: Animals; Antihypertensive Agents; Desoxycorticosterone Acetate; Disease Models, Animal; Endothelium, | 2020 |
P-Selectin Glycoprotein Ligand-1 Deficiency Protects Against Aortic Aneurysm Formation Induced by DOCA Plus Salt.
Topics: Animals; Aortic Aneurysm; Cell Adhesion; Cell Movement; Cells, Cultured; Desoxycorticosterone Acetat | 2022 |
Use of chlorisondamine to assess the neurogenic contribution to blood pressure in mice: An evaluation of method.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiovascular System; Chlorisondamine; Desoxycorticosteron | 2021 |
Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension.
Topics: Angiotensin III; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Brain; Desoxycor | 2021 |
Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Desoxycorticosterone Acetate; Dis | 2021 |
Renal Denervation by Noninvasive Stereotactic Radiotherapy Induces Persistent Reduction of Sympathetic Activity in a Hypertensive Swine Model.
Topics: Animals; Blood Pressure; Desoxycorticosterone Acetate; Disease Models, Animal; Female; Hypertension; | 2021 |
Brain Renin-Angiotensin System: Does It Exist?
Topics: Amides; Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Blood-Brain Barrier; Brain; Desoxy | 2017 |
A New Mouse Model for Introduction of Aortic Aneurysm by Implantation of Deoxycorticosterone Acetate Pellets or Aldosterone Infusion in the Presence of High Salt.
Topics: Aldosterone; Animals; Aortic Aneurysm; Blood Pressure Determination; Desoxycorticosterone Acetate; D | 2017 |
The effects of chronic FAAH inhibition on myocardial lipid metabolism in normotensive and DOCA-salt hypertensive rats.
Topics: Amidohydrolases; Animals; Benzamides; Blood Pressure; Carbamates; Chromatography, Gas; Chromatograph | 2017 |
Deoxycorticosterone acetate-salt hypertension activates placental growth factor in the spleen to couple sympathetic drive and immune system activation.
Topics: Animals; Blood Pressure; Desoxycorticosterone Acetate; Disease Models, Animal; Ganglia, Sympathetic; | 2018 |
Macrophage-dependent impairment of α
Topics: Adrenergic Fibers; Animals; Arterial Pressure; Calcium Channels, N-Type; Calcium Signaling; Desoxyco | 2018 |
Renal Na-handling defect associated with PER1-dependent nondipping hypertension in male mice.
Topics: Animals; Blood Pressure; Circadian Rhythm; Desoxycorticosterone Acetate; Disease Models, Animal; Epi | 2018 |
Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Desoxycorticosterone Acetate; Diseas | 2018 |
Deletion of BMAL1 in Smooth Muscle Cells Protects Mice From Abdominal Aortic Aneurysms.
Topics: Aldosterone; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; ARNTL Transcript | 2018 |
Chronic Blockade of Brain Endothelin Receptor Type-A (ET
Topics: Animals; Blood Pressure; Catecholamines; Desoxycorticosterone Acetate; Disease Models, Animal; Endot | 2018 |
Prevention Effect of Antiplatelets on Aneurysm Rupture in a Mouse Intracranial Aneurysm Model.
Topics: Aneurysm, Ruptured; Animals; Aspirin; Cerebral Arteries; Cilostazol; Cyclooxygenase 2; Cyclooxygenas | 2018 |
Adiponectin attenuates kidney injury and fibrosis in deoxycorticosterone acetate-salt and angiotensin II-induced CKD mice.
Topics: Adiponectin; Angiotensin II; Animals; Cell Proliferation; Desoxycorticosterone Acetate; Disease Mode | 2018 |
Lesion of the OVLT markedly attenuates chronic DOCA-salt hypertension in rats.
Topics: Animals; Arterial Pressure; Blood Pressure Monitoring, Ambulatory; Desoxycorticosterone Acetate; Dis | 2018 |
The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension.
Topics: Amidohydrolases; Animals; Benzamides; Carbamates; Desoxycorticosterone Acetate; Disease Models, Anim | 2018 |
TRPV4 activation in rat carotid artery in DOCA hypertension involves eNOS and endothelium-derived contractile factor (EDCF).
Topics: Animals; Blood Pressure; Carotid Artery, Common; Desoxycorticosterone Acetate; Disease Models, Anima | 2019 |
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Blood Pressure; Chemotaxis, | 2019 |
The effects of LXR agonist GW3965 on vascular reactivity and inflammation in hypertensive rat aorta.
Topics: Animals; Aorta; Benzoates; Benzylamines; Blood Pressure; Cardiovascular Diseases; Desoxycorticostero | 2018 |
Endothelial cell mineralocorticoid receptors oppose VEGF-induced gene expression and angiogenesis.
Topics: Aldosterone; Animals; Aorta; Cells, Cultured; Desoxycorticosterone Acetate; Disease Models, Animal; | 2019 |
Inhibition of endoplasmic reticulum stress protected DOCA-salt hypertension-induced vascular dysfunction.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Apoptosis; Blood Pressure; Calcium; Cell Prolifer | 2019 |
Changes in physicochemical properties of kidney cells membrane as a consequence of hypertension and treatment of hypertensive rats with FAAH inhibitor.
Topics: Amidohydrolases; Animals; Benzamides; Carbamates; Cell Membrane; Chromatography, High Pressure Liqui | 2019 |
Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance.
Topics: Animals; Desoxycorticosterone Acetate; Diastole; Disease Models, Animal; Heart Failure; Heart Ventri | 2019 |
Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats.
Topics: Actins; Albumins; Animals; Apoptosis; Biomarkers; Creatinine; Desoxycorticosterone Acetate; Disease | 2019 |
Renal Inflammation in DOCA-Salt Hypertension.
Topics: Animals; Blood Pressure; Cytokines; Desoxycorticosterone Acetate; Disease Models, Animal; Hypertensi | 2019 |
Transiently proliferating perivascular microglia harbor M1 type and precede cerebrovascular changes in a chronic hypertension model.
Topics: Animals; Antigens, CD; Blood Pressure; Brain; Calcium-Binding Proteins; Carboxymethylcellulose Sodiu | 2019 |
Exacerbated effects of prorenin on hypothalamic magnocellular neuronal activity and vasopressin plasma levels during salt-sensitive hypertension.
Topics: Animals; Blood Pressure; Desoxycorticosterone Acetate; Disease Models, Animal; Hypertension; Hypotha | 2019 |
Etoricoxib attenuates effect of antihypertensives in a rodent model of DOCA-salt induced hypertension.
Topics: Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Blood Pressure; Cyclooxygenas | 2013 |
Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury.
Topics: Actin Depolymerizing Factors; Acute Kidney Injury; Albuminuria; Animals; cdc42 GTP-Binding Protein; | 2013 |
Pharmacokinetics of drugs in spontaneously or secondary hypertensive rats.
Topics: Age Factors; Animals; Cytochrome P-450 Enzyme System; Desoxycorticosterone Acetate; Disease Models, | 2014 |
HDAC inhibition suppresses cardiac hypertrophy and fibrosis in DOCA-salt hypertensive rats via regulation of HDAC6/HDAC8 enzyme activity.
Topics: Animals; Cardiomegaly; Desoxycorticosterone Acetate; Disease Models, Animal; Enzyme Activation; Fibr | 2013 |
Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.
Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin- | 2013 |
Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension.
Topics: Animals; Desoxycorticosterone Acetate; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; He | 2013 |
Synergistic effects of high blood cholesterol and hypertension on leukocyte and platelet recruitment in the cerebral microcirculation.
Topics: Animals; Apolipoproteins E; Blood Platelets; Cell Adhesion; Cell Movement; Cerebrovascular Circulati | 2014 |
Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes.
Topics: Animals; Antibodies; Desoxycorticosterone Acetate; Disease Models, Animal; Down-Regulation; Forkhead | 2014 |
Possible hepatoprotective effects of lacidipine in irradiated DOCA-salt hypertensive albino rats.
Topics: Alanine Transaminase; Animals; Blood Pressure; Desoxycorticosterone Acetate; Dihydropyridines; Disea | 2013 |
Characterization of musclin as a new target for treatment of hypertension.
Topics: Animals; Calcium; Desoxycorticosterone Acetate; Disease Models, Animal; Gene Expression Regulation; | 2014 |
Interactions of PPAR α and GLUT4 in DOCA/salt-induced renal injury in mice.
Topics: Animals; Desoxycorticosterone Acetate; Disease Models, Animal; Fenofibrate; Glucose Transporter Type | 2013 |
Effect of DOCA/salt hypertension on CRF expression in the amygdala and the autonomic stress response in conscious rats.
Topics: Amygdala; Animals; Autonomic Nervous System; Baroreflex; Blood Pressure; Consciousness; Corticotropi | 2014 |
[Effect of inhibiting brain reactive oxygen species on sympathetic nerve activity in DOCA-salt hypertensive rats].
Topics: Animals; Antioxidants; Arterial Pressure; Blood Pressure; Brain; Cyclic N-Oxides; Desoxycorticostero | 2014 |
Brain-targeted angiotensin-converting enzyme 2 overexpression attenuates neurogenic hypertension by inhibiting cyclooxygenase-mediated inflammation.
Topics: Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Brain; Cyclooxygenase 1; Cyclooxygenase 2; D | 2015 |
Brain ACE2 overexpression reduces DOCA-salt hypertension independently of endoplasmic reticulum stress.
Topics: Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Blood Pressure; Brain; Desoxycorticosterone Ac | 2015 |
Parabrachial lesions in rats disrupt sodium appetite induced by furosemide but not by calcium deprivation.
Topics: Analysis of Variance; Animals; Appetite; Calcium; Calcium Chloride; Conditioning, Psychological; Des | 2015 |
Complement-mediated macrophage polarization in perivascular adipose tissue contributes to vascular injury in deoxycorticosterone acetate-salt mice.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Bone Marrow Transplantation; Cell Communication; | 2015 |
Transglutaminase activity is decreased in large arteries from hypertensive rats compared with normotensive controls.
Topics: Animals; Aorta, Thoracic; Cells, Cultured; Desoxycorticosterone Acetate; Disease Models, Animal; Dow | 2015 |
Supplementation of apelin increase plasma levels of nesfatin-1 in normal and DOCA-salt hypertensive rats.
Topics: Animals; Apelin; Calcium-Binding Proteins; Desoxycorticosterone Acetate; Disease Models, Animal; DNA | 2015 |
Involvement of endothelins in deoxycorticosterone acetate-salt hypertension through the modulation of noradrenergic transmission in the rat posterior hypothalamus.
Topics: Adrenergic Neurons; Animals; Blood Pressure; Desoxycorticosterone Acetate; Disease Models, Animal; E | 2015 |
Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats.
Topics: Analysis of Variance; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Pressure; Brain; Cytok | 2015 |
Brain endoplasmic reticulum stress mechanistically distinguishes the saline-intake and hypertensive response to deoxycorticosterone acetate-salt.
Topics: Analysis of Variance; Animals; Blood Pressure; Brain; Desoxycorticosterone Acetate; Disease Models, | 2015 |
Angiotensin II regulates brain (pro)renin receptor expression through activation of cAMP response element-binding protein.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; A | 2015 |
Curative effect of sesame oil in a rat model of chronic kidney disease.
Topics: Albuminuria; Animals; Antioxidants; Collagen; Desoxycorticosterone Acetate; Disease Models, Animal; | 2015 |
Development of a Model of Chronic Kidney Disease in the C57BL/6 Mouse with Properties of Progressive Human CKD.
Topics: Angiotensin II; Animals; Desoxycorticosterone Acetate; Disease Models, Animal; Disease Progression; | 2015 |
Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
Topics: Administration, Oral; Adrenalectomy; Aldosterone; Animals; Antihypertensive Agents; Binding, Competi | 2015 |
Beneficial effects of angiotensin-(1-7) against deoxycorticosterone acetate-induced diastolic dysfunction occur independently of changes in blood pressure.
Topics: Angiotensin I; Animals; Blood Pressure; Calcium; Calcium Signaling; Desoxycorticosterone Acetate; Di | 2015 |
Resveratrol via activation of AMPK lowers blood pressure in DOCA-salt hypertensive mice.
Topics: AMP-Activated Protein Kinases; Animals; Anticarcinogenic Agents; Blood Pressure; Desoxycorticosteron | 2015 |
Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/CREB signaling system.
Topics: Adrenergic alpha-2 Receptor Agonists; Aminopyridines; Animals; Antihypertensive Agents; Benzamides; | 2015 |
PGC-1α overexpression suppresses blood pressure elevation in DOCA-salt hypertensive mice.
Topics: Animals; Aorta; Blood Pressure; Cells, Cultured; Desoxycorticosterone Acetate; Disease Models, Anima | 2015 |
A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
Topics: Animals; Cardiomyopathies; Connectin; Desoxycorticosterone Acetate; Diet, Western; Dilatation, Patho | 2015 |
Mechanism of the anti-hypertensive property of the naturally occurring phenolic, malabaricone C in DOCA-salt rats.
Topics: Animals; Antihypertensive Agents; Antioxidants; Aorta; Desoxycorticosterone Acetate; Disease Models, | 2016 |
Deoxycorticosterone Acetate/Salt-Induced Cardiac But Not Renal Injury Is Mediated By Endothelial Mineralocorticoid Receptors Independently From Blood Pressure.
Topics: Animals; Blood Pressure; Cells, Cultured; Desoxycorticosterone Acetate; Disease Models, Animal; Endo | 2016 |
Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-γ Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension.
Topics: Animals; Blood Pressure; Desoxycorticosterone Acetate; Disease Models, Animal; DNA; Gene Expression | 2016 |
Endothelial dysfunction in DOCA-salt-hypertensive mice: role of neuronal nitric oxide synthase-derived hydrogen peroxide.
Topics: Animals; Desoxycorticosterone Acetate; Disease Models, Animal; Endothelium, Vascular; Hydrogen Perox | 2016 |
Role of Axl in T-Lymphocyte Survival in Salt-Dependent Hypertension.
Topics: Adoptive Transfer; Animals; Apoptosis; Axl Receptor Tyrosine Kinase; Blood Pressure; CD4-Positive T- | 2016 |
Effects of equol on deoxycorticosterone acetate salt-induced hypertension and associated vascular dementia in rats.
Topics: Acetylcholinesterase; Animals; Blood Pressure; Body Weight; Brain; Catalase; Dementia, Vascular; Des | 2016 |
Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension.
Topics: Animals; Desoxycorticosterone Acetate; Disease Models, Animal; Hypertension; Kidney; Male; Nephritis | 2016 |
High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice.
Topics: Animals; Bacteria; Blood Pressure; Desoxycorticosterone Acetate; Dietary Fiber; Dietary Supplements; | 2017 |
Prevention of hypertension-induced vascular dementia by Lactobacillus paracasei subsp. paracasei NTU 101-fermented products.
Topics: Animals; Aorta; Behavior, Animal; Blood Pressure; Cultured Milk Products; Cytokines; Dementia; Desox | 2017 |
Apelin-induced hemorheological alterations in DOCA-salt hypertensive rats.
Topics: Animals; Apelin; Desoxycorticosterone Acetate; Disease Models, Animal; Erythrocyte Aggregation; Eryt | 2014 |